---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-031311"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:20:26.378040+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics raises ~$1.9M net in $0.30/share public offering for clinical studies

## Summary
- Gross proceeds $2,002,500 from 6,675,000 shares at $0.30/share; underwriter exercised over-allotment for 1,001,250 additional shares.
- Net proceeds ~$1.9M after underwriting discounts and expenses; offering closed June 13, 2025.
- Representative's Warrants for 383,812 shares (5% of offering) issued at $0.375 exercise price, 5-year term.
- Proceeds to fund INVINCIBLE-4 data readout (expected H1 2026) and continue INVINCIBLE-3 study maintenance.
- ThinkEquity acted as sole book-running manager; shares traded on Nasdaq under INTS.

## SEC filing metadata
- accession: 0001628280-25-031311
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/0001628280-25-031311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/intensity-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-031311
- JSON: https://secwatch.observer/filing/0001628280-25-031311.json
- Plain text: https://secwatch.observer/filing/0001628280-25-031311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.